Microbe-derived extracellular vesicles as a smart drug delivery system
10.12793/tcp.2018.26.3.103
- Author:
Jinho YANG
1
;
Eun Kyoung KIM
;
Andrea MCDOWELL
;
Yoon Keun KIM
Author Information
1. Institute of MD Healthcare Inc., Seoul 03923, Republic of Korea. ykkim@mdhc.kr
- Publication Type:Review
- Keywords:
Drug delivery system;
Extracellular vesicles;
Microbiome;
Pharmabiotics
- MeSH:
Biomarkers;
Drug Delivery Systems;
Extracellular Vesicles;
Membranes;
Microbiota;
Nucleic Acids
- From:Translational and Clinical Pharmacology
2018;26(3):103-110
- CountryRepublic of Korea
- Language:English
-
Abstract:
The human microbiome is known to play an essential role in influencing host health. Extracellular vesicles (EVs) have also been reported to act on a variety of signaling pathways, distally transport cellular components such as proteins, lipids, and nucleic acid, and have immunomodulatory effects. Here we shall review the current understanding of the intersectionality of the human microbiome and EVs in the emerging field of microbiota-derived EVs and their pharmacological potential. Microbes secrete several classes of EVs: outer membrane vesicles (OMVs), membrane vesicles (MVs), and apoptotic bodies. EV biogenesis is unique to each cell and regulated by sophisticated signaling pathways. EVs are primarily composed of lipids, proteins, nucleic acids, and recent evidence suggests they may also carry metabolites. These components interact with host cells and control various cellular processes by transferring their constituents. The pharmacological potential of microbiomederived EVs as vaccine candidates, biomarkers, and a smart drug delivery system is a promising area of future research. Therefore, it is necessary to elucidate in detail the mechanisms of microbiome-derived EV action in host health in a multi-disciplinary manner.
